Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2008
03/13/2008US20080063737 Treatment of stretch marks acne and skin blemishes; aloe vera; vitamin E; antibiotic ointment
03/13/2008US20080063699 Method of Administering Cationic Liposomes Comprising an Active Drug
03/13/2008US20080063674 Cosmetic Composition Containing Protein Hydrolysates
03/13/2008US20080063644 immunohistochemistry; skin thickening caused by ultraviolet treated by using the antibody; inhibit production of IFN-.gamma; promoting keratinocyte differentiation induction and suppressing epidermal thickening, skin cancer; inhibiting growth of keratinocytes; promotes hair growth; hyperplasia
03/13/2008US20080063639 Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodies
03/13/2008US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium
03/13/2008US20080063618 a mixture of zinc pyrithione in combination with water soluble zinc containing materials such as zinc oxide and anionic, cationic, nonionic, amphoteric or zwitterionic surfactants, used as antidandruff agents with improved efficacy
03/13/2008US20080063607 Oleaginous pharmaceutical and cosmetic foam
03/13/2008CA2663091A1 Modulators of interleukin-1 receptor-associated kinase
03/13/2008CA2662628A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
03/13/2008CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators
03/13/2008CA2661102A1 Thiophene derivatives as s1p1/edg1 receptor agonists
03/12/2008EP1897553A1 Inhibitor of stem cell proliferation and uses thereof
03/12/2008EP1896405A2 Organic compounds
03/12/2008EP1896404A1 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
03/12/2008EP1896043A2 Method of using oxidative reductive potential water solution in dental applications
03/12/2008EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis
03/12/2008EP1896024A1 Methods and compositions using 4[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperridin-3yl) isoindole-1,3-dione for the treatment of prevention of cutaneous lupus
03/12/2008EP1896016A2 Method for solubilizing metronidazole
03/12/2008EP1896010A2 Method and composition to treat skin ulcers
03/12/2008EP1895843A2 Micogel topical formulations
03/12/2008EP1686972B1 Sprayable composition for the administration of vitamin d derivatives
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1434590B1 Method for inhibiting the formation of seromas using factor xiii
03/12/2008EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/12/2008EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
03/12/2008EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
03/12/2008CN101141982A Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
03/12/2008CN101141956A Use of CRTH2 antagonist compounds in therapy
03/12/2008CN101139393A KDR peptides and vaccines containing the same
03/12/2008CN101139392A KDR peptides and vaccines containing the same
03/12/2008CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists
03/12/2008CN101138629A Recombinant human keratinocyte growth factor-2 freeze dried agent
03/12/2008CN101138611A Compound radiating empyrosis aerosol
03/12/2008CN101138608A Chinese traditional medicine composition for treating alopecia
03/12/2008CN101138600A Wound quick-healing medicine
03/12/2008CN101138592A Preparation method for treating internal hemorrhoid and Chinese medicine suppository thereof
03/12/2008CN101138589A Medicine for treating psoriasis and preparation method thereof
03/12/2008CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
03/12/2008CN101138560A Nitrofuran gelling agent and method of preparing the same
03/12/2008CN101138559A Novel medicine preparations for curing psoriasis
03/12/2008CN101138557A Chlorhexidine acetate partial film forming gel composition and uses thereof
03/12/2008CN101138556A Terbinafine or its salt film forming gel composition and uses thereof
03/12/2008CN101138543A Centella asiatica partial film forming gel composition and uses thereof
03/12/2008CN100374458C 17aª‡-D-high valent alkyneestradiol-3-ethyl ester and its synthesis and preparation method, pharmaceutical composition using the said compound as active ingredient
03/12/2008CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/12/2008CN100374156C Health products for face care and body care
03/12/2008CN100374152C Hypersensitivity reaction inhibitor
03/12/2008CN100374141C Wound-treating powder
03/12/2008CN100374137C Beautifying and spot eliminating health care product and its prepn process
03/12/2008CN100374131C Liniment for treating sweaty feet, odour feet and beriberi and preparation method thereof
03/12/2008CN100374128C Leucoderma treating Chinese medicine
03/12/2008CN100374117C Weiding ointment and its prepn. process
03/12/2008CN100374110C Local preparation containing poloxamer and other microbe killing agent and applicator
03/12/2008CN100374109C Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne
03/12/2008CN100374099C Antimicrobial composition
03/12/2008CN100374044C Primary composition containing lipophilic bioactive compound
03/11/2008US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent
03/11/2008US7342045 Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342029 Substituted indoles
03/11/2008US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
03/11/2008US7341746 Chinese herbs extract
03/11/2008US7341712 Synergistic effect protecting the skin against light; use for skin tanning; impregnated wipes
03/11/2008CA2468929C Medical adhesive and medical covering agent using ultraviolet ray curable chitosan derivative
03/11/2008CA2421880C Resorcinol derivatives
03/11/2008CA2335104C Arylalkanoylpyridazines
03/11/2008CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/06/2008WO2008028192A2 Variable region sequences of il-31 monoclonal antibodies and methods of use
03/06/2008WO2008026965A1 Substituted pyrrolo[4,3-b]indoles, combinatorial and focused libraries, pharmacological composition and a method for the production and use thereof
03/06/2008WO2008026704A1 Isoquinoline derivative
03/06/2008WO2008026507A1 Skin whitening agent
03/06/2008WO2008026381A1 Nail patch
03/06/2008WO2008026349A1 Therapeutic agent for telogen effluvium
03/06/2008WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT
03/06/2008WO2008026014A1 Management of non septic patients suffering from partial thickness burns during the first 48 postburn hours by administration of activated protein c
03/06/2008WO2008025847A2 Use of c7 sugars in prevention and treatment of mycoses
03/06/2008WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors
03/06/2008WO2008025094A1 Method of treatment of photodermatoses
03/06/2008WO2008025074A1 Method for reducing incidence or rate of development of skin cancers and related conditions
03/06/2008WO2008004165A3 Use of c-glycoside derivatives as pro-desquamating active agents
03/06/2008WO2007147370A3 Pseudoceramides and pharmaceutical and/or cosmetic compositions designed for administration to the skin containing the same
03/06/2008WO2007120606A8 Methods for modulating formation and progression of cellulite
03/06/2008WO2007089688A3 Na/k-atpase ligand
03/06/2008WO2007085946A3 Novel cosmetic and dermatological compositions based on algae extracts
03/06/2008WO2006057755A3 Compositions containing cotinus coggygria extract and use thereof on mucosal tissues
03/06/2008US20080058519 Quinazoline ditosylate salt compounds
03/06/2008US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids
03/06/2008US20080058412 1-(4-((R,S)-5-[1,2]dithiolan-3-ylpentyloxy)-3,5-dimethylphenyl)-3-(4-carboxydimethylmethyloxy-3,5-dimethylphenyl)prop-2-en-1-one; peroxisome proliferator activated receptor agonist; lipid or glucose metabolism: hyperlipidemia, diabetes, obesity; dermatologicalal: psoriasis, atopic dermatitis, acne
03/06/2008US20080058400 Skin external preparation
03/06/2008US20080058363 Pharmaceutical composition for treating fecal incontinence and anal itch
03/06/2008US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent
03/06/2008US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example
03/06/2008US20080058283 Therapy for skin disorders
03/06/2008US20080058281 Skin Lightening Compositions Comprising Vitamines and Flavonoids
03/06/2008US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators
03/06/2008US20080058252 Use of C5A receptor antagonist in the treatment of fibrosis
03/06/2008US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer
03/06/2008US20080057139 Skin-care water
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 1065